3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
2
Unknown
1
Terminated
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Carcinoma, Non-Small-Cell Lung
13
Lung Neoplasms
2
Esophageal Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sjogren's Syndrome
1
Scleroderma, Systemic
1
Retinoblastoma
1
Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC)
1
Resectable Non-small Cell Lung Cancer
1
Resectable Lung Non-Small Cell Carcinoma
1
Recurrence
1
Psoriasis
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Sclerosis
1
Lupus Erythematosus, Systemic
1
Inflammatory Bowel Diseases
1
Hematologic Neoplasms
1
Dermatomyositis
1
Crohn Disease
1
Colitis, Ulcerative
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Bronchogenic
1
Bronchial Neoplasms
1
Autoimmune Diseases
1
Arthritis, Rheumatoid
1
Arthritis, Psoriatic
1
Advanced Non-small Cell Lung Cancer
1
Interventions
Bevacizumab
40
Paclitaxel
35
Carboplatin
28
pembrolizumab
21
Cyclophosphamide
15
Specimen Handling
14
Cisplatin
13
olaparib
11
Blood Specimen Collection
11
niraparib
10
fludarabine
10
Magnetic Resonance Spectroscopy
9
Drug Therapy
9
liposomal doxorubicin
8
Topotecan
8
Taxes
8
Gemcitabine
8
Biopsy
8
Fulvestrant
7
Doxorubicin
6
cemiplimab
5
abemaciclib
5
Surveys and Questionnaires
5
Standard of Care
5
Injections
5
Fluorouracil
5
Cytoreduction Surgical Procedures
5
trastuzumab deruxtecan
4
mirvetuximab soravtansine
4
aldesleukin
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Ovarian Neoplasms
×
Platinum Compounds
×
Clear all
NCT07340164
2026-04-20
TROY
Yonsei University
Phase 2
Recruiting
116 enrolled